Group 1: Company Overview - Yunnan Betaini Biotechnology Group Co., Ltd. has completed the construction of its new central factory, which began operations on March 13, 2023, significantly expanding its production capacity with an expected annual output value of 5 billion RMB [1] - The new factory employs smart production technology, featuring high automation across multiple processes including extraction, formulation, filling, packaging, and warehousing, which reduces labor costs and shortens production cycles [1] Group 2: Future Growth Points - Brand upgrade and momentum building through the "Winona 2.0" brand initiative, focusing on the sensitive skin market to enhance brand strength [2] - New brand incubation and ecosystem development with sub-brands such as Winona Baby, AOXMED, Beforteen, Za, and PURE&MILD, aiming for diversified brand development and investment in raw material startups [2] - Expansion into overseas markets with the establishment of a Southeast Asia headquarters in Bangkok, utilizing localized operations and multi-channel marketing [2] - Increased investment in R&D, focusing on dermatology and functional cosmetics to support product innovation and market competitiveness [2]
贝泰妮(300957) - 2024年6月13日投资者关系活动记录表